Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FAM129A |
| Upstream (Parents) |
|---|
| (<<) FCGR2A → FAM129A |
| (<<) VIM → FAM129A |
| (<<) FCGR1B → FAM129A |
| (<<) RASSF2 → FAM129A |
| Downstream (Children) |
|---|
| FAM129A → C21orf7 (>>) |
| FAM129A → PTGER3 (>>) |
| FAM129A → IKZF1 (>>) |
| FAM129A → PRKG1 (>>) |
| FAM129A → PCDHA2 (>>) |
| FAM129A → MGC3771 (>>) |
| FAM129A → QKI (>>) |
| FAM129A → DNAJC28 (>>) |
| FAM129A → LOC100134355///PRIM2 (>>) |
| FAM129A → SNCA (>>) |
| FAM129A → LXN (>>) |
| FAM129A → L2HGDH (>>) |
| FAM129A → RPL29P7///SUMO1P2 (>>) |
